US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.37

-0.0200-0.19%

Post-market: 10.370.00000.00%17:13 EDT

Volume:236.01K

Turnover:2.44M

Market Cap:518.51M

PE:-8.98

High:10.55

Open:10.39

Low:10.15

Close:10.39

Loading ...

Overview Company News Filings

Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conference

Why Is Theravance Bio (TBPH) Up 0.4% Since Last Earnings Report?

Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology

Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

Theravance Biopharma Reports Strong Q4 2024 Earnings

Theravance's Q4 Loss In Line With Estimates, Sales Beat

Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...

Theravance Biopharma Reports Record 2024 Financial Results

Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates

Theravance Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary

Theravance Biopharma Q4 Adj EPS $(0.05) Beats $(0.21) Estimate, Sales $18.75M Beat $17.09M Estimate

Theravance Biopharma reports Q4 EPS (31c), consensus (8c)

BRIEF-Theravance Biopharma Q4 Operating Income USD -9.2 Million

Theravance Biopharma Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Theravance Biopharma: Strategic Milestones and Revenue Forecasts Justify Buy Rating

Theravance Biopharma Inc expected to post a loss of 21 cents a share - Earnings Preview

Theravance Biopharma to Participate in an Upcoming Investor Conference

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation

Simply Wall St.

Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TBPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma","latestPrice":10.37,"timestamp":1746216000000,"preClose":10.39,"halted":0,"volume":236007,"hourTrading":{"tag":"盘后","latestPrice":10.37,"preClose":10.37,"latestTime":"17:13 EDT","volume":36815,"amount":381771.98,"timestamp":1746220389901},"delay":0,"floatShares":22758721,"shares":50001332,"eps":-1.154994,"marketStatus":"Market Closed","change":-0.02,"latestTime":"05-02 16:00:00 EDT","open":10.39,"high":10.55,"low":10.15,"amount":2441734.20572,"amplitude":0.038499,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.154994,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1400212800000,"exchange":"NASDAQ","adjPreClose":10.39,"postHourTrading":{"tag":"盘后","latestPrice":10.37,"preClose":10.37,"latestTime":"17:13 EDT","volume":36815,"amount":381771.98,"timestamp":1746220389901},"volumeRatio":0.9141226388121324,"impliedVol":0.4788,"impliedVolPercentile":0.416},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBPH\",,,,,undefined,":{"symbol":"TBPH","floatShares":22758721,"roa":"-7.21%","roe":"-29.04%","lyrEps":-1.154994,"volumeRatio":0.9141226388121324,"shares":50001332,"dividePrice":0,"high":10.55,"amplitude":0.038499,"preClose":10.39,"low":10.15,"week52Low":7.44,"pbRate":"2.95","psRate":"8.05","week52High":10.9,"institutionHeld":0,"latestPrice":10.37,"eps":-1.154994,"divideRate":0,"volume":236007,"delay":0,"ttmEps":-1.154994,"open":10.39,"prevYearClose":9.41,"prevWeekClose":9.75,"prevMonthClose":9.77,"prevQuarterClose":8.93,"fiveDayClose":9.75,"twentyDayClose":8.77,"sixtyDayClose":9.72,"earningDate":1746633600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529962983","title":"Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529962983","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529962983?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:00","pubTimestamp":1745488800,"startTime":"0","endTime":"0","summary":"DUBLIN, April 24, 2025 /PRNewswire/ -- Theravance Biopharma, Inc.  will report its first quarter 2025 financial results and provide a business update after market close on Thursday, May 8, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EDT  that day.A replay of the webcast will be available on Theravance Biopharma's website for 30 days through June 7, 2025.Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI  inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease . Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension  in patients with Multiple System Atrophy , has the potential to be a first in class t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-report-first-quarter-100000578.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-report-first-quarter-100000578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1815336091.USD","MSA","LU0053671581.USD","LU2125909916.SGD","LU0728928796.USD","BK4007","BK4143","LU0757428866.USD","LU2125909759.SGD","TBPH","LU1923622291.USD","LU2211815571.USD"],"gpt_icon":0},{"id":"2523916436","title":"Theravance Biopharma to Participate in an Upcoming Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2523916436","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523916436?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:00","pubTimestamp":1743415200,"startTime":"0","endTime":"0","summary":"DUBLIN, March 31, 2025 /PRNewswire/ --Theravance Biopharma, Inc.  will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on Wednesday, April 9 at 11:30 am PDT .Members of Theravance Biopharma senior management will also be hosting one-on-one meetings at the conference. To attend the fireside chat and schedule meetings with management, please contact your Jones representative or email Yuki Gonzalez, Vice President, Marketing & Corporate Access .Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI  inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease . Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthosta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-100000693.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-100000693.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0757428866.USD","TBPH","BK4143","BK4007","LU2125909916.SGD","LU0728928796.USD","LU2211815571.USD","MSA","LU2125909759.SGD","LU1923622291.USD","LU1815336091.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2523689962","title":"Why Is Theravance Bio (TBPH) Up 0.4% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2523689962","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523689962?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:30","pubTimestamp":1743175848,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Theravance Biopharma . Shares have added about 0.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Theravance Bio due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.It turns out, fresh estimates have trended downward during the past month.The consensus estimate has shifted 17.59% due to these changes.Currently, Theravance Bio has an average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. Following the exact same course, the stock was allocated a grade of F on the value side, putting it in the lowest quintile for this investment strategy.Theravance Biopharma, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-theravance-bio-tbph-0-153048122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2522290543","title":"Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology","url":"https://stock-news.laohu8.com/highlight/detail?id=2522290543","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522290543?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"DUBLIN, March 27, 2025 /PRNewswire/ -- Theravance Biopharma, Inc.   today announced new analyses of the initial Phase 3 program of ampreloxetine  supporting its selective and differentiated pharmacodynamic profile will be presented at the 77th Annual Meeting of the American Academy of Neurology  Meeting, taking place April 5-9, 2025, in San Diego, California. Results from these initial studies led to the initiation of a Phase 3 confirmatory study  addressingnOH in patients with multiple system atrophy, which is currently ongoing.Analyses will be presented consecutively in a platform session on Monday, April 7, 2025, starting at 11:15 AM Pacific Daylight Time :. NET-Inhibition with Ampreloxetine, Blood Pressure, and Catecholamines in Patients with Neurogenic Orthostatic Hypotension","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-present-ampreloxetine-analyses-100000154.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-present-ampreloxetine-analyses-100000154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU0053671581.USD","LU2125909916.SGD","MSA","AFG","LU2125909759.SGD","LU1815336091.USD","TBPH","AAN","BK4117","LU0728928796.USD","BK4178","LU2211815571.USD","BK4107","BK4143","LU1923622291.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2514932854","title":"Theravance Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2514932854","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514932854?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:35","pubTimestamp":1740738942,"startTime":"0","endTime":"0","summary":"NasdaqGM:TBPH Earnings and Revenue Growth February 28th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.9%. Earnings per share  missed analyst estimates by 9.8%.Looking ahead, revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 4.0% from a week ago.Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Theravance Biopharma's balance sheet and an in-depth analysis of the company's financial position.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-full-2024-earnings-103542612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2514361565","title":"Theravance Biopharma Reports Strong Q4 2024 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514361565?lang=en_us&edition=fundamental","pubTime":"2025-02-28 09:57","pubTimestamp":1740707871,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (($TBPH)) has held its Q4 earnings call. Read on for the main highlights of the call. Theravance Biopharma’s recent earnings c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theravance-biopharma-reports-strong-q4-2024-earnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theravance-biopharma-reports-strong-q4-2024-earnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH"],"gpt_icon":0},{"id":"2514038988","title":"Theravance's Q4 Loss In Line With Estimates, Sales Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038988","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514038988?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:41","pubTimestamp":1740663660,"startTime":"0","endTime":"0","summary":"Theravance Biopharma TBPH reported fourth-quarter 2024 adjusted net loss of 5 cents per share, which came in line with the Zacks Consensus Estimate. In the year-ago quarter, the company had recorded earnings of 3 cents per share.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The reported loss excludes share-based compensation expense, income tax expense and non-cash interest expense. Including these items, the company incurred a loss of 31 cents per share in the fourth quarter compared with a loss of 17 cents in the year-ago quarter.Theravance and Viatris have collaborated for the development and commercialization of Yupelri, which is approved in the United States for the maintenance treatment of patients with chronic obstructive pulmonary disease.Theravance has some royalty interest in GSK plc’s GSK chronic obstructive pulmonary disease medicine, Trelegy Ellipta. In February 2025, TBPH earned a $50 million milestone payment from partner Royalty Pharma based on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravances-q4-loss-line-estimates-134100106.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH","VTRS"],"gpt_icon":0},{"id":"2514825084","title":"Theravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514825084","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514825084?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:26","pubTimestamp":1740641211,"startTime":"0","endTime":"0","summary":"Upell Net Sales: Increased 10% year-over-year in Q4 2024, reaching $66.7 million.Full Year Upell Sales: $239 million, with highest profitability since launch.Trilogy Milestone Payment: $50 million earned from Royalty Pharma based on GSK's 2024 sales.Collaboration Revenue: Grew by 8% to approximately $19 million in Q4 2024.Operating Expenses: Increased to $22 million in Q4 2024, due to commercial and R&D activities.Cash Utilization: $3 million in Q4 2024, $14 million for the full year.Cash Balance: Ended 2024 with $88 million, excluding the $50 million milestone receipt.2025 R&D Expense Guidance: $32 to $38 million, excluding share-based compensation.2025 SG&A Expense Guidance: $50 to $60 million, excluding share-based compensation.2025 Share-Based Compensation Guidance: $18 to $20 million.Non-GAAP Losses and Cash Burn: Expected to be similar to 2024 levels.GuruFocus has detected 4 Warning Signs with TBPH.Theravance Biopharma Inc  anticipates typical seasonal dips in reported net sales ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-inc-tbph-q4-072651832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH"],"gpt_icon":0},{"id":"2514845135","title":"Theravance Biopharma Reports Record 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514845135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514845135?lang=en_us&edition=fundamental","pubTime":"2025-02-27 12:33","pubTimestamp":1740630814,"startTime":"0","endTime":"0","summary":"Theravance Biopharma ( ($TBPH) ) has released its Q4 earnings. Here is a breakdown of the information Theravance Biopharma presented to its investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theravance-biopharma-reports-record-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theravance-biopharma-reports-record-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2514897835","title":"Theravance Biopharma (TBPH) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514897835","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514897835?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:15","pubTimestamp":1740608105,"startTime":"0","endTime":"0","summary":"Theravance Biopharma  came out with a quarterly loss of $0.05 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.10 per share when it actually produced a loss of $0.06, delivering a surprise of 40%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Theravance Bio , which belongs to the Zacks Medical - Drugs industry, posted revenues of $18.75 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.50%. This compares to year-ago revenues of $17.57 million. The company has topped consensus revenue estimates two times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-tbph-reports-q4-221505056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TBPH","PSTV"],"gpt_icon":0},{"id":"2514956748","title":"Theravance Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514956748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514956748?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:01","pubTimestamp":1740607318,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc reports results for the quarter ended December 31 - Earnings SummaryTheravance Biopharma Inc TBPH.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL5N3PH2YG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514898256","title":"Theravance Biopharma Q4 Adj EPS $(0.05) Beats $(0.21) Estimate, Sales $18.75M Beat $17.09M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898256","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898256?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:25","pubTimestamp":1740605128,"startTime":"0","endTime":"0","summary":"Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.21) by 76.19 percent. This is a 70.59 percent increase over losses of $(0.17) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43990714/theravance-biopharma-q4-adj-eps-0-05-beats-0-21-estimate-sales-18-75m-beat-17-09m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Theravance Biopharma Q4 Adj EPS $(0.05) Beats $(0.21) Estimate, Sales $18.75M Beat $17.09M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514898148","title":"Theravance Biopharma reports Q4 EPS (31c), consensus (8c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898148?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:18","pubTimestamp":1740604727,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $18.75M, consensus $17.09M. “Theravance Biopharma (TBPH) ended 2024 on a high note, having collaborated closely with Viatris to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-reports-q4-eps-31c-consensus-8c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theravance-biopharma-reports-q4-eps-31c-consensus-8c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH"],"gpt_icon":0},{"id":"2514860897","title":"BRIEF-Theravance Biopharma Q4 Operating Income USD -9.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514860897","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514860897?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603954,"startTime":"0","endTime":"0","summary":"BRIEF-Theravance Biopharma Q4 Operating Income USD -9.2 Million\n\n\nFeb 26 (Reuters) - Theravance Biopharma Q4 adjusted net income USD -2.472 million.\n\nQ4 net income USD -15.528 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLX36F77B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514093921","title":"Theravance Biopharma Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514093921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514093921?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:17","pubTimestamp":1740485820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TBPH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 07:17 ET (12:17 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514982067","title":"Theravance Biopharma: Strategic Milestones and Revenue Forecasts Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514982067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514982067?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:17","pubTimestamp":1740482255,"startTime":"0","endTime":"0","summary":"Douglas Tsao, an analyst from H.C. Wainwright, maintained the Buy rating on Theravance Biopharma (TBPH – Research Report). The associated price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/theravance-biopharma-strategic-milestones-and-revenue-forecasts-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/theravance-biopharma-strategic-milestones-and-revenue-forecasts-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBPH"],"gpt_icon":0},{"id":"2514670958","title":"Theravance Biopharma Inc  expected to post a loss of 21 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514670958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514670958?lang=en_us&edition=fundamental","pubTime":"2025-02-25 05:31","pubTimestamp":1740432665,"startTime":"0","endTime":"0","summary":"Theravance Biopharma Inc  expected to post a loss of21cents a share - Earnings Preview Theravance Biopharma Inc TBPH.OQ TBPH.O is expected to show a fall in quarterly revenue when it reports  results ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL5N3PF27C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2512483984","title":"Theravance Biopharma to Participate in an Upcoming Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483984","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512483984?lang=en_us&edition=fundamental","pubTime":"2025-02-20 19:00","pubTimestamp":1740049200,"startTime":"0","endTime":"0","summary":"DUBLIN, Feb. 20, 2025 /PRNewswire/ --Theravance Biopharma, Inc.  will present at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4 at 11:50 am EST  and will be hosting in-person meetings with the investment community at the conference.Webcast of the event may be accessed by visiting Theravance.com, under the Investors section, Events and Presentations. Replay of the webcast will be archived on the Company's website for 30 days.Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI  inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease . Ampreloxetine, its late-stage investigational once-daily norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension  in patients with Multiple System Atro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-110000340.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-participate-upcoming-investor-110000340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2125909916.SGD","LU0053671581.USD","LU0728928796.USD","BK4143","LU0757428866.USD","LU2125909759.SGD","MSA","LU1923622291.USD","LU2211815571.USD","BK4007","TBPH","LU1815336091.USD"],"gpt_icon":0},{"id":"2511243385","title":"Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2511243385","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511243385?lang=en_us&edition=fundamental","pubTime":"2025-02-13 23:28","pubTimestamp":1739460508,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.Given this risk, we thought we'd take a look at whether Theravance Biopharma  shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Let's start with an examination of the business' cash, relative to its cash burn.When Might Theravance Biopharma Run Out Of Money?As you can probably tell by now, we're not too worried about Theravance Biopharma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-were-not-concerned-152828237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","TSYW.SI","BK4588","BK4007","USJW.SI","BK4112","MNQmain","TQQQ","IE00B3QW5Z07.USD","QID",".IXIC","NQmain","NDAQ","SQQQ","BK4585","QLD","LU2095319765.USD","LU2210150020.SGD","TBPH","IE00BKPKM429.USD","PSQ","LU2210149790.SGD","USAW.SI","NVIW.SI"],"gpt_icon":1},{"id":"2510651322","title":"Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510651322","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510651322?lang=en_us&edition=fundamental","pubTime":"2025-02-12 19:00","pubTimestamp":1739358000,"startTime":"0","endTime":"0","summary":"DUBLIN, Ireland, Feb. 12, 2025 /PRNewswire/ --Theravance Biopharma, Inc.  will report its fourth quarter and full year 2024 financial results and provide a business update after market close on Wednesday, February 26, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EST  that day.To participate in the live call by telephone, please pre-register here. Those interested in listening to the conference call live via the internet may do so by visiting Theravance Biopharma's website at www.theravance.com, under the Investors section, Events and Presentations.Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference in people's lives. In pursuit of its purpose, Theravance Biopharma leverages decades of expertise, which has led to the development of FDA-approved YUPELRI  inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease . Ampreloxetine, its late-stage investigational ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/theravance-biopharma-report-fourth-quarter-110000641.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theravance-biopharma-report-fourth-quarter-110000641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1923622291.USD","BK4143","LU0757428866.USD","LU0728928796.USD","LU0053671581.USD","LU2125909759.SGD","LU2211815571.USD","BK4007","LU2125909916.SGD","TBPH","MSA","LU1815336091.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBPH\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"TBPH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"defaultRemindTime":1746734400000,"name":null,"time":"Post Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-02-26","symbol":"TBPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-11-12","symbol":"TBPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-08-05","symbol":"TBPH","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-05-13","symbol":"TBPH","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1723003200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TBPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TBPH","date":"2025-05-02","current":-9.208299,"percent":0.100572,"low":-10.895737,"twenty":-8.359977,"median":-4.428094,"eighty":-1.976367,"high":0.904616,"avg":-4.653342,"sd":3.425272,"marketCap":519513839},"quantilePoints":[{"date":"2020-05-08","current":-7.174216,"twenty":-8.104143,"median":-5.688858,"eighty":-4.025458,"marketCap":1771514718},{"date":"2020-05-15","current":-7.003036,"twenty":-8.104143,"median":-5.702965,"eighty":-4.061913,"marketCap":1729245670},{"date":"2020-05-22","current":-6.995371,"twenty":-8.104143,"median":-5.716143,"eighty":-4.11164,"marketCap":1727353026},{"date":"2020-05-29","current":-6.451173,"twenty":-8.104143,"median":-5.736387,"eighty":-4.131774,"marketCap":1592975307},{"date":"2020-06-05","current":-6.601914,"twenty":-8.104143,"median":-5.762244,"eighty":-4.178503,"marketCap":1630197305},{"date":"2020-06-12","current":-6.451173,"twenty":-8.104143,"median":-5.769353,"eighty":-4.198886,"marketCap":1592975307},{"date":"2020-06-19","current":-5.588888,"twenty":-8.104143,"median":-5.773576,"eighty":-4.218777,"marketCap":1380052865},{"date":"2020-06-26","current":-5.367887,"twenty":-8.104143,"median":-5.773576,"eighty":-4.252681,"marketCap":1325481632},{"date":"2020-07-02","current":-5.242696,"twenty":-8.104143,"median":-5.773576,"eighty":-4.267317,"marketCap":1294568448},{"date":"2020-07-10","current":-5.523737,"twenty":-8.104143,"median":-5.773576,"eighty":-4.291364,"marketCap":1363965392},{"date":"2020-07-17","current":-5.669368,"twenty":-8.104143,"median":-5.773576,"eighty":-4.331101,"marketCap":1399925626},{"date":"2020-07-24","current":-5.301459,"twenty":-8.104143,"median":-5.773576,"eighty":-4.364331,"marketCap":1309078718},{"date":"2020-07-31","current":-4.961655,"twenty":-8.104143,"median":-5.773576,"eighty":-4.382367,"marketCap":1225171504},{"date":"2020-08-07","current":-4.196887,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1133062832},{"date":"2020-08-14","current":-3.92888,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1060707347},{"date":"2020-08-21","current":-4.341766,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1172176891},{"date":"2020-08-28","current":-4.074743,"twenty":-8.104143,"median":-5.773576,"eighty":-4.387324,"marketCap":1100086901},{"date":"2020-09-04","current":-4.065126,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1097490399},{"date":"2020-09-11","current":-3.996426,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1078943067},{"date":"2020-09-18","current":-4.221477,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1139701568},{"date":"2020-09-25","current":-3.723996,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1005393303},{"date":"2020-10-02","current":-3.548694,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":958065628},{"date":"2020-10-09","current":-4.264118,"twenty":-8.104143,"median":-5.773576,"eighty":-4.38874,"marketCap":1151213706},{"date":"2020-10-16","current":-4.389672,"twenty":-8.104143,"median":-5.773576,"eighty":-4.391068,"marketCap":1185110554},{"date":"2020-10-23","current":-4.607616,"twenty":-8.104143,"median":-5.773576,"eighty":-4.400195,"marketCap":1243950365},{"date":"2020-10-30","current":-4.479693,"twenty":-8.104143,"median":-5.773576,"eighty":-4.421814,"marketCap":1209413954},{"date":"2020-11-06","current":-3.765315,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1073826562},{"date":"2020-11-13","current":-3.961969,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1129910058},{"date":"2020-11-20","current":-3.861013,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1101118465},{"date":"2020-11-27","current":-3.681535,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1049933411},{"date":"2020-12-04","current":-3.825118,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1090881454},{"date":"2020-12-11","current":-4.175099,"twenty":-8.104143,"median":-5.773576,"eighty":-4.422194,"marketCap":1190692309},{"date":"2020-12-18","current":-4.365794,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1245076428},{"date":"2020-12-24","current":-4.208751,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1200289506},{"date":"2020-12-31","current":-3.986647,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1136948003},{"date":"2021-01-08","current":-3.961969,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1129910058},{"date":"2021-01-15","current":-4.036004,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1151023892},{"date":"2021-01-22","current":-4.067412,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1159981277},{"date":"2021-01-29","current":-4.181829,"twenty":-8.104143,"median":-5.773576,"eighty":-4.423085,"marketCap":1192611748},{"date":"2021-02-05","current":-4.464507,"twenty":-8.104143,"median":-5.773576,"eighty":-4.427269,"marketCap":1273228208},{"date":"2021-02-12","current":-4.410663,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1257872692},{"date":"2021-02-19","current":-4.215481,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1202208946},{"date":"2021-02-26","current":-3.833982,"twenty":-8.104143,"median":-5.773576,"eighty":-4.431573,"marketCap":1065912143},{"date":"2021-03-05","current":-4.500359,"twenty":-8.109294,"median":-5.774844,"eighty":-4.440716,"marketCap":1251176293},{"date":"2021-03-12","current":-4.775702,"twenty":-8.109294,"median":-5.774844,"eighty":-4.454509,"marketCap":1327726411},{"date":"2021-03-19","current":-4.87751,"twenty":-8.109294,"median":-5.774844,"eighty":-4.466582,"marketCap":1356030656},{"date":"2021-03-26","current":-4.80658,"twenty":-8.104143,"median":-5.773576,"eighty":-4.479554,"marketCap":1336310980},{"date":"2021-04-01","current":-4.719785,"twenty":-8.104143,"median":-5.773576,"eighty":-4.486573,"marketCap":1312180425},{"date":"2021-04-09","current":-4.914488,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505471,"marketCap":1366311129},{"date":"2021-04-16","current":-5.09277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.507772,"marketCap":1415876592},{"date":"2021-04-23","current":-4.961404,"twenty":-8.109294,"median":-5.774844,"eighty":-4.519721,"marketCap":1379354672},{"date":"2021-04-30","current":-4.630644,"twenty":-8.109294,"median":-5.774844,"eighty":-4.543546,"marketCap":1287397694},{"date":"2021-05-07","current":-4.694319,"twenty":-8.109294,"median":-5.774844,"eighty":-4.555614,"marketCap":1289261968},{"date":"2021-05-14","current":-4.449502,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1222024508},{"date":"2021-05-21","current":-4.145262,"twenty":-8.109294,"median":-5.774844,"eighty":-4.55769,"marketCap":1138467277},{"date":"2021-05-28","current":-4.107232,"twenty":-8.109294,"median":-5.774844,"eighty":-4.54777,"marketCap":1128022623},{"date":"2021-06-04","current":-3.938475,"twenty":-8.109294,"median":-5.774844,"eighty":-4.533645,"marketCap":1081674471},{"date":"2021-06-11","current":-4.325904,"twenty":-8.109294,"median":-5.774844,"eighty":-4.513199,"marketCap":1188079383},{"date":"2021-06-18","current":-4.164277,"twenty":-8.109294,"median":-5.774844,"eighty":-4.505684,"marketCap":1143689604},{"date":"2021-06-25","current":-4.085012,"twenty":-8.109294,"median":-5.774844,"eighty":-4.486884,"marketCap":1121919864},{"date":"2021-07-02","current":-3.762924,"twenty":-8.109294,"median":-5.774844,"eighty":-4.481775,"marketCap":1033460797},{"date":"2021-07-09","current":-3.590097,"twenty":-8.109294,"median":-5.774844,"eighty":-4.472621,"marketCap":985994957},{"date":"2021-07-16","current":-3.47226,"twenty":-8.109294,"median":-5.774844,"eighty":-4.457472,"marketCap":953631884},{"date":"2021-07-23","current":-3.553436,"twenty":-8.109294,"median":-5.774844,"eighty":-4.449502,"marketCap":975926445},{"date":"2021-07-30","current":-3.398939,"twenty":-8.109294,"median":-5.774844,"eighty":-4.430832,"marketCap":933494861},{"date":"2021-08-06","current":-3.615643,"twenty":-8.109294,"median":-5.772308,"eighty":-4.424502,"marketCap":955111963},{"date":"2021-08-13","current":-3.760269,"twenty":-8.109294,"median":-5.764166,"eighty":-4.416356,"marketCap":993316441},{"date":"2021-08-20","current":-3.907676,"twenty":-8.109294,"median":-5.757271,"eighty":-4.403183,"marketCap":1032255621},{"date":"2021-08-27","current":-2.28898,"twenty":-8.109294,"median":-5.730996,"eighty":-4.390152,"marketCap":604659342},{"date":"2021-09-03","current":-2.355731,"twenty":-8.109294,"median":-5.714021,"eighty":-4.38615,"marketCap":622292178},{"date":"2021-09-10","current":-2.352949,"twenty":-8.109294,"median":-5.703573,"eighty":-4.378008,"marketCap":621557477},{"date":"2021-09-17","current":-1.977479,"twenty":-8.109294,"median":-5.688858,"eighty":-4.365944,"marketCap":522372773},{"date":"2021-09-24","current":-1.952447,"twenty":-8.074271,"median":-5.669407,"eighty":-4.356033,"marketCap":515760460},{"date":"2021-10-01","current":-2.069261,"twenty":-8.045944,"median":-5.638655,"eighty":-4.341342,"marketCap":546617923},{"date":"2021-10-08","current":-2.280637,"twenty":-8.016163,"median":-5.625476,"eighty":-4.330717,"marketCap":602455238},{"date":"2021-10-15","current":-2.22223,"twenty":-7.997331,"median":-5.608563,"eighty":-4.307524,"marketCap":587026506},{"date":"2021-10-22","current":-2.147136,"twenty":-7.997331,"median":-5.5825,"eighty":-4.289657,"marketCap":567189565},{"date":"2021-10-29","current":-2.161042,"twenty":-7.997331,"median":-5.562665,"eighty":-4.280637,"marketCap":570863073},{"date":"2021-11-05","current":-2.944324,"twenty":-7.997331,"median":-5.541795,"eighty":-4.270191,"marketCap":664904866},{"date":"2021-11-12","current":-2.676073,"twenty":-7.97491,"median":-5.530125,"eighty":-4.26185,"marketCap":604326781},{"date":"2021-11-19","current":-2.728289,"twenty":-7.915096,"median":-5.521827,"eighty":-4.240905,"marketCap":616118523},{"date":"2021-11-26","current":-2.614066,"twenty":-7.915096,"median":-5.494408,"eighty":-4.224725,"marketCap":590324087},{"date":"2021-12-03","current":-2.535742,"twenty":-7.915096,"median":-5.486755,"eighty":-4.218356,"marketCap":572636474},{"date":"2021-12-10","current":-3.178652,"twenty":-7.905554,"median":-5.462928,"eighty":-4.210236,"marketCap":717822299},{"date":"2021-12-17","current":-3.508266,"twenty":-7.863621,"median":-5.43799,"eighty":-4.192263,"marketCap":792257671},{"date":"2021-12-23","current":-3.518056,"twenty":-7.79203,"median":-5.430638,"eighty":-4.183439,"marketCap":794468622},{"date":"2021-12-31","current":-3.606171,"twenty":-7.706812,"median":-5.421098,"eighty":-4.174698,"marketCap":814367187},{"date":"2022-01-07","current":-4.2295,"twenty":-7.490651,"median":-5.415781,"eighty":-4.171972,"marketCap":955131108},{"date":"2022-01-14","current":-3.224341,"twenty":-7.39119,"median":-5.403277,"eighty":-4.154162,"marketCap":728140073},{"date":"2022-01-21","current":-2.738079,"twenty":-7.283381,"median":-5.391459,"eighty":-4.143836,"marketCap":618329475},{"date":"2022-01-28","current":-2.858829,"twenty":-7.255155,"median":-5.375582,"eighty":-4.130131,"marketCap":645597878},{"date":"2022-02-04","current":-2.881673,"twenty":-7.164617,"median":-5.360998,"eighty":-4.115812,"marketCap":650756766},{"date":"2022-02-11","current":-3.005686,"twenty":-7.129748,"median":-5.345665,"eighty":-4.106391,"marketCap":678762153},{"date":"2022-02-18","current":-3.136227,"twenty":-7.086122,"median":-5.318068,"eighty":-4.092363,"marketCap":708241508},{"date":"2022-02-25","current":-3.784218,"twenty":-7.055237,"median":-5.296367,"eighty":-4.074174,"marketCap":754671493},{"date":"2022-03-04","current":-3.599506,"twenty":-6.986071,"median":-5.279742,"eighty":-4.064449,"marketCap":717835162},{"date":"2022-03-11","current":-3.704383,"twenty":-6.907174,"median":-5.270085,"eighty":-4.051495,"marketCap":738750234},{"date":"2022-03-18","current":-3.917881,"twenty":-6.883977,"median":-5.238484,"eighty":-4.041607,"marketCap":781327346},{"date":"2022-03-25","current":-3.695631,"twenty":-6.821381,"median":-5.213693,"eighty":-4.033509,"marketCap":737004982},{"date":"2022-04-01","current":-3.600481,"twenty":-6.748055,"median":-5.173949,"eighty":-4.023592,"marketCap":718029571},{"date":"2022-04-08","current":-3.707049,"twenty":-6.708949,"median":-5.154002,"eighty":-4.012509,"marketCap":739282032},{"date":"2022-04-14","current":-3.779363,"twenty":-6.646559,"median":-5.123213,"eighty":-4.006133,"marketCap":753703344},{"date":"2022-04-22","current":-3.486301,"twenty":-6.620365,"median":-5.107869,"eighty":-3.983031,"marketCap":695259077},{"date":"2022-04-29","current":-3.672795,"twenty":-6.58534,"median":-5.089808,"eighty":-3.961969,"marketCap":732450883},{"date":"2022-05-06","current":-4.869112,"twenty":-6.539981,"median":-5.065962,"eighty":-3.95749,"marketCap":709395462},{"date":"2022-05-13","current":-4.764624,"twenty":-6.488349,"median":-5.043541,"eighty":-3.95749,"marketCap":694172384},{"date":"2022-05-20","current":-4.566098,"twenty":-6.452269,"median":-5.004378,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-05-27","current":-4.827317,"twenty":-6.407665,"median":-4.988003,"eighty":-3.95749,"marketCap":703306231},{"date":"2022-06-03","current":-4.733278,"twenty":-6.37586,"median":-4.971167,"eighty":-3.95749,"marketCap":689605460},{"date":"2022-06-10","current":-4.482508,"twenty":-6.338788,"median":-4.96153,"eighty":-3.95749,"marketCap":653070071},{"date":"2022-06-17","current":-4.539976,"twenty":-6.300389,"median":-4.946484,"eighty":-3.95749,"marketCap":661442765},{"date":"2022-06-24","current":-4.696707,"twenty":-6.267019,"median":-4.910906,"eighty":-3.95749,"marketCap":684277383},{"date":"2022-07-01","current":-5.083311,"twenty":-6.240179,"median":-4.890862,"eighty":-3.95749,"marketCap":740602773},{"date":"2022-07-08","current":-4.822092,"twenty":-6.216799,"median":-4.87956,"eighty":-3.95749,"marketCap":702545077},{"date":"2022-07-15","current":-4.581771,"twenty":-6.209146,"median":-4.869112,"eighty":-3.95749,"marketCap":667531996},{"date":"2022-07-22","current":-5.062413,"twenty":-6.191017,"median":-4.862682,"eighty":-3.95749,"marketCap":737558158},{"date":"2022-07-29","current":-4.59222,"twenty":-6.179545,"median":-4.82892,"eighty":-3.95749,"marketCap":669054304},{"date":"2022-08-05","current":-6.555529,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":665248534},{"date":"2022-08-12","current":-7.237614,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":734465814},{"date":"2022-08-19","current":-7.034268,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":713830458},{"date":"2022-08-26","current":-6.815859,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":691666558},{"date":"2022-09-02","current":-7.056862,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":716123276},{"date":"2022-09-09","current":-6.906235,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":700837827},{"date":"2022-09-16","current":-7.584055,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":769622347},{"date":"2022-09-23","current":-7.523805,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":763508167},{"date":"2022-09-30","current":-6.731347,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":683090347},{"date":"2022-10-07","current":-6.578663,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":667596187},{"date":"2022-10-14","current":-6.585302,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":668269847},{"date":"2022-10-21","current":-6.532195,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":662880574},{"date":"2022-10-28","current":-6.631771,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":672985460},{"date":"2022-11-04","current":-6.611855,"twenty":-6.159218,"median":-4.827317,"eighty":-3.95749,"marketCap":670964483},{"date":"2022-11-11","current":0.89271,"twenty":-6.146499,"median":-4.820655,"eighty":-3.940021,"marketCap":759213828},{"date":"2022-11-18","current":0.859441,"twenty":-6.127876,"median":-4.801195,"eighty":-3.931298,"marketCap":730920145},{"date":"2022-11-25","current":0.838193,"twenty":-6.120221,"median":-4.790159,"eighty":-3.924806,"marketCap":712849417},{"date":"2022-12-02","current":0.871404,"twenty":-6.112485,"median":-4.781893,"eighty":-3.907695,"marketCap":741094393},{"date":"2022-12-09","current":0.857961,"twenty":-6.085916,"median":-4.773739,"eighty":-3.868192,"marketCap":729661903},{"date":"2022-12-16","current":0.86745,"twenty":-6.066767,"median":-4.764624,"eighty":-3.84486,"marketCap":737731896},{"date":"2022-12-23","current":0.893545,"twenty":-6.05758,"median":-4.750843,"eighty":-3.819542,"marketCap":759924378},{"date":"2022-12-30","current":0.887219,"twenty":-6.047108,"median":-4.743423,"eighty":-3.802491,"marketCap":754544382},{"date":"2023-01-06","current":0.885638,"twenty":-6.047108,"median":-4.728054,"eighty":-3.791192,"marketCap":753199384},{"date":"2023-01-13","current":0.893545,"twenty":-6.047108,"median":-4.715093,"eighty":-3.772761,"marketCap":759924378},{"date":"2023-01-20","current":0.877335,"twenty":-6.047108,"median":-4.707156,"eighty":-3.760269,"marketCap":746138139},{"date":"2023-01-27","current":0.859543,"twenty":-6.044599,"median":-4.691483,"eighty":-3.742884,"marketCap":731006902},{"date":"2023-02-03","current":0.842147,"twenty":-6.044599,"median":-4.686259,"eighty":-3.723165,"marketCap":716211914},{"date":"2023-02-10","current":0.820796,"twenty":-6.044599,"median":-4.676099,"eighty":-3.710822,"marketCap":698054429},{"date":"2023-02-17","current":0.825541,"twenty":-6.044599,"median":-4.655962,"eighty":-3.702405,"marketCap":702089425},{"date":"2023-02-24","current":0.780468,"twenty":-6.044599,"median":-4.653259,"eighty":-3.691816,"marketCap":663756957},{"date":"2023-03-03","current":0.725859,"twenty":-6.044599,"median":-4.644464,"eighty":-3.673453,"marketCap":633045253},{"date":"2023-03-10","current":0.736672,"twenty":-6.044599,"median":-4.630524,"eighty":-3.653022,"marketCap":642474924},{"date":"2023-03-17","current":0.738834,"twenty":-6.044599,"median":-4.621402,"eighty":-3.638541,"marketCap":644360858},{"date":"2023-03-24","current":0.758296,"twenty":-6.044599,"median":-4.613117,"eighty":-3.627973,"marketCap":661334266},{"date":"2023-03-31","current":0.786576,"twenty":-6.04375,"median":-4.605891,"eighty":-3.615693,"marketCap":685997879},{"date":"2023-04-06","current":0.803975,"twenty":-6.04375,"median":-4.603005,"eighty":-3.605794,"marketCap":701172025},{"date":"2023-04-14","current":0.863421,"twenty":-6.044599,"median":-4.603005,"eighty":-3.587389,"marketCap":753017027},{"date":"2023-04-21","current":0.835873,"twenty":-6.044599,"median":-4.603005,"eighty":-3.563925,"marketCap":728991294},{"date":"2023-04-28","current":0.783676,"twenty":-6.044599,"median":-4.597235,"eighty":-3.536548,"marketCap":683468854},{"date":"2023-05-05","current":0.814849,"twenty":-6.044599,"median":-4.596353,"eighty":-3.51414,"marketCap":710655867},{"date":"2023-05-12","current":0.765928,"twenty":-6.044599,"median":-4.585694,"eighty":-3.495212,"marketCap":670945000},{"date":"2023-05-19","current":0.718518,"twenty":-6.044599,"median":-4.581354,"eighty":-3.485421,"marketCap":629414426},{"date":"2023-05-26","current":0.728415,"twenty":-6.044599,"median":-4.581354,"eighty":-3.453986,"marketCap":638084046},{"date":"2023-06-01","current":0.737652,"twenty":-6.044599,"median":-4.571181,"eighty":-3.439329,"marketCap":646175692},{"date":"2023-06-16","current":0.685528,"twenty":-6.047145,"median":-4.556078,"eighty":-3.259587,"marketCap":600515692},{"date":"2023-06-22","current":0.704002,"twenty":-6.047145,"median":-4.547581,"eighty":-3.182568,"marketCap":616698983},{"date":"2023-06-27","current":0.676291,"twenty":-6.047145,"median":-4.545402,"eighty":-3.136227,"marketCap":592424047},{"date":"2023-07-07","current":0.67761,"twenty":-6.047256,"median":-4.542588,"eighty":-3.012213,"marketCap":593579996},{"date":"2023-07-14","current":0.649899,"twenty":-6.047256,"median":-4.522012,"eighty":-2.971093,"marketCap":569305059},{"date":"2023-07-21","current":0.636703,"twenty":-6.047256,"median":-4.50904,"eighty":-2.924751,"marketCap":557745566},{"date":"2023-07-28","current":0.634724,"twenty":-6.047256,"median":-4.503406,"eighty":-2.867967,"marketCap":556011642},{"date":"2023-08-04","current":0.654518,"twenty":-6.047256,"median":-4.48687,"eighty":-2.794864,"marketCap":573350882},{"date":"2023-08-11","current":0.609287,"twenty":-6.045447,"median":-4.479345,"eighty":-2.74787,"marketCap":529187302},{"date":"2023-08-18","current":0.585572,"twenty":-6.045447,"median":-4.462624,"eighty":-2.728289,"marketCap":508590191},{"date":"2023-08-25","current":0.575235,"twenty":-6.045447,"median":-4.449502,"eighty":-2.674115,"marketCap":499611963},{"date":"2023-09-01","current":0.578883,"twenty":-6.033007,"median":-4.428611,"eighty":-2.593833,"marketCap":502780750},{"date":"2023-09-08","current":0.589828,"twenty":-6.016567,"median":-4.420338,"eighty":-2.539658,"marketCap":512287108},{"date":"2023-09-15","current":0.590436,"twenty":-5.994874,"median":-4.403007,"eighty":-2.392444,"marketCap":512815239},{"date":"2023-09-22","current":0.547871,"twenty":-5.980167,"median":-4.390072,"eighty":-2.342937,"marketCap":475846067},{"date":"2023-09-29","current":0.509563,"twenty":-5.971921,"median":-4.382328,"eighty":-2.283974,"marketCap":442573811},{"date":"2023-10-06","current":0.550912,"twenty":-5.945804,"median":-4.367183,"eighty":-2.22223,"marketCap":478486722},{"date":"2023-10-13","current":0.558209,"twenty":-5.937293,"median":-4.348344,"eighty":-2.190524,"marketCap":484824294},{"date":"2023-10-20","current":0.545439,"twenty":-5.919911,"median":-4.338527,"eighty":-2.170498,"marketCap":473733542},{"date":"2023-10-27","current":0.561857,"twenty":-5.91888,"median":-4.325904,"eighty":-2.158261,"marketCap":487993080},{"date":"2023-11-03","current":0.594693,"twenty":-5.91888,"median":-4.301844,"eighty":-2.068148,"marketCap":516512157},{"date":"2023-11-10","current":-8.790683,"twenty":-5.931389,"median":-4.294914,"eighty":-2.058135,"marketCap":501464510},{"date":"2023-11-17","current":-8.982734,"twenty":-5.941785,"median":-4.294914,"eighty":-2.058135,"marketCap":512420041},{"date":"2023-11-24","current":-9.139866,"twenty":-5.951889,"median":-4.294914,"eighty":-2.058135,"marketCap":521383657},{"date":"2023-12-01","current":-9.148596,"twenty":-5.974498,"median":-4.294914,"eighty":-2.058135,"marketCap":521881635},{"date":"2023-12-08","current":-9.25335,"twenty":-5.976931,"median":-4.29496,"eighty":-2.058135,"marketCap":527857379},{"date":"2023-12-15","current":-9.611263,"twenty":-5.982249,"median":-4.29496,"eighty":-2.058135,"marketCap":548274504},{"date":"2023-12-22","current":-9.89061,"twenty":-6.037727,"median":-4.29496,"eighty":-2.058135,"marketCap":564209821},{"date":"2023-12-29","current":-9.87315,"twenty":-6.055696,"median":-4.294914,"eighty":-2.058135,"marketCap":563213864},{"date":"2024-01-05","current":-10.056471,"twenty":-6.065646,"median":-4.293344,"eighty":-2.058135,"marketCap":573671416},{"date":"2024-01-12","current":-8.537525,"twenty":-6.075519,"median":-4.293344,"eighty":-2.058135,"marketCap":487023129},{"date":"2024-01-19","current":-8.310556,"twenty":-6.115014,"median":-4.291775,"eighty":-2.058135,"marketCap":474075684},{"date":"2024-01-26","current":-8.65101,"twenty":-6.124513,"median":-4.293344,"eighty":-2.058135,"marketCap":493496852},{"date":"2024-02-02","current":-7.996292,"twenty":-6.153311,"median":-4.293344,"eighty":-2.058135,"marketCap":456148452},{"date":"2024-02-09","current":-7.175711,"twenty":-6.191017,"median":-4.293344,"eighty":-2.058135,"marketCap":409338458},{"date":"2024-02-16","current":-7.568542,"twenty":-6.210395,"median":-4.293344,"eighty":-2.058135,"marketCap":431747498},{"date":"2024-02-23","current":-7.572907,"twenty":-6.222321,"median":-4.293344,"eighty":-2.058135,"marketCap":431996487},{"date":"2024-03-01","current":-8.252985,"twenty":-6.244375,"median":-4.294914,"eighty":-2.058135,"marketCap":455507000},{"date":"2024-03-08","current":-7.583413,"twenty":-6.26237,"median":-4.294914,"eighty":-2.058135,"marketCap":418551312},{"date":"2024-03-15","current":-7.5136,"twenty":-6.300389,"median":-4.294914,"eighty":-2.058135,"marketCap":414698135},{"date":"2024-03-22","current":-7.819031,"twenty":-6.378281,"median":-4.294914,"eighty":-2.058135,"marketCap":431555783},{"date":"2024-03-28","current":-7.862664,"twenty":-6.418847,"median":-4.294914,"eighty":-2.058135,"marketCap":433964019},{"date":"2024-04-05","current":-7.97611,"twenty":-6.461522,"median":-4.293344,"eighty":-2.058135,"marketCap":440225431},{"date":"2024-04-12","current":-7.856801,"twenty":-6.51133,"median":-4.293344,"eighty":-2.058135,"marketCap":433640398},{"date":"2024-04-19","current":-8.094352,"twenty":-6.533511,"median":-4.293344,"eighty":-2.058135,"marketCap":446751586},{"date":"2024-04-26","current":-8.041563,"twenty":-6.555878,"median":-4.294914,"eighty":-2.058135,"marketCap":443837988},{"date":"2024-05-03","current":-8.243922,"twenty":-6.57917,"median":-4.294914,"eighty":-2.058135,"marketCap":455006778},{"date":"2024-05-10","current":-8.331904,"twenty":-6.603902,"median":-4.294914,"eighty":-2.058135,"marketCap":459862773},{"date":"2024-05-17","current":-10.428621,"twenty":-6.620365,"median":-4.294914,"eighty":-2.058135,"marketCap":466878950},{"date":"2024-05-24","current":-9.287991,"twenty":-6.638909,"median":-4.294914,"eighty":-2.058135,"marketCap":415814065},{"date":"2024-05-31","current":-9.222812,"twenty":-6.650555,"median":-4.295005,"eighty":-2.058135,"marketCap":412896071},{"date":"2024-06-07","current":-9.646475,"twenty":-6.694809,"median":-4.325904,"eighty":-2.058135,"marketCap":431863029},{"date":"2024-06-14","current":-9.32058,"twenty":-6.714869,"median":-4.341236,"eighty":-2.058135,"marketCap":417273061},{"date":"2024-06-21","current":-9.407486,"twenty":-6.729069,"median":-4.351769,"eighty":-2.058135,"marketCap":421163719},{"date":"2024-06-28","current":-9.049002,"twenty":-6.740828,"median":-4.365284,"eighty":-2.052016,"marketCap":405114755},{"date":"2024-07-05","current":-9.244538,"twenty":-6.781753,"median":-4.377444,"eighty":-2.052016,"marketCap":413868736},{"date":"2024-07-12","current":-10.135316,"twenty":-6.814349,"median":-4.384999,"eighty":-2.052016,"marketCap":453747979},{"date":"2024-07-15","current":-10.178769,"twenty":-6.816504,"median":-4.387059,"eighty":-2.052016,"marketCap":455693308},{"date":"2024-08-02","current":-10.895737,"twenty":-6.836947,"median":-4.368573,"eighty":-1.983598,"marketCap":487791236},{"date":"2024-08-09","current":-8.18135,"twenty":-6.880736,"median":-4.368573,"eighty":-1.983598,"marketCap":373503160},{"date":"2024-08-16","current":-8.840759,"twenty":-6.897996,"median":-4.368573,"eighty":-1.983598,"marketCap":403607184},{"date":"2024-08-23","current":-8.583574,"twenty":-6.949119,"median":-4.368573,"eighty":-1.983598,"marketCap":391865884},{"date":"2024-08-30","current":-8.797895,"twenty":-6.995146,"median":-4.368573,"eighty":-1.983598,"marketCap":401650301},{"date":"2024-09-06","current":-8.755031,"twenty":-7.046318,"median":-4.368573,"eighty":-1.983598,"marketCap":399693418},{"date":"2024-09-13","current":-8.690734,"twenty":-7.071924,"median":-4.368573,"eighty":-1.983598,"marketCap":396758093},{"date":"2024-09-20","current":-8.797895,"twenty":-7.099928,"median":-4.368573,"eighty":-1.983598,"marketCap":401650301},{"date":"2024-09-27","current":-8.637154,"twenty":-7.126973,"median":-4.368573,"eighty":-1.983598,"marketCap":394311988},{"date":"2024-10-04","current":-8.680018,"twenty":-7.161703,"median":-4.368573,"eighty":-1.983598,"marketCap":396268872},{"date":"2024-10-11","current":-8.637154,"twenty":-7.181652,"median":-4.368573,"eighty":-1.983598,"marketCap":394311988},{"date":"2024-10-18","current":-9.237254,"twenty":-7.281351,"median":-4.377727,"eighty":-1.983598,"marketCap":421708355},{"date":"2024-10-25","current":-9.258686,"twenty":-7.375637,"median":-4.389672,"eighty":-1.983598,"marketCap":422686797},{"date":"2024-10-31","current":-9.076513,"twenty":-7.418279,"median":-4.403886,"eighty":-1.983598,"marketCap":414370043},{"date":"2024-11-08","current":-9.376563,"twenty":-7.489976,"median":-4.428094,"eighty":-1.977479,"marketCap":428068226},{"date":"2024-11-15","current":-9.526083,"twenty":-7.523805,"median":-4.428611,"eighty":-1.977479,"marketCap":470598012},{"date":"2024-11-22","current":-9.565899,"twenty":-7.56596,"median":-4.428611,"eighty":-1.977479,"marketCap":472564984},{"date":"2024-11-29","current":-9.207551,"twenty":-7.583413,"median":-4.428611,"eighty":-1.977479,"marketCap":454862238},{"date":"2024-12-06","current":-9.794844,"twenty":-7.647109,"median":-4.428611,"eighty":-1.977479,"marketCap":483875072},{"date":"2024-12-13","current":-9.824706,"twenty":-7.697025,"median":-4.428611,"eighty":-1.977479,"marketCap":485350301},{"date":"2024-12-20","current":-9.685348,"twenty":-7.725675,"median":-4.428611,"eighty":-1.977479,"marketCap":478465900},{"date":"2024-12-27","current":-9.814752,"twenty":-7.784125,"median":-4.428611,"eighty":-1.977479,"marketCap":484858558},{"date":"2025-01-03","current":-9.237414,"twenty":-7.839159,"median":-4.428611,"eighty":-1.977479,"marketCap":456337466},{"date":"2025-01-10","current":-9.008469,"twenty":-7.86433,"median":-4.428611,"eighty":-1.976923,"marketCap":445027378},{"date":"2025-01-17","current":-8.401268,"twenty":-7.941203,"median":-4.428611,"eighty":-1.976923,"marketCap":415031058},{"date":"2025-01-24","current":-9.625624,"twenty":-8.016634,"median":-4.428611,"eighty":-1.976923,"marketCap":475515442},{"date":"2025-01-31","current":-9.625624,"twenty":-8.067959,"median":-4.428611,"eighty":-1.976923,"marketCap":475515442},{"date":"2025-02-07","current":-9.466358,"twenty":-8.136704,"median":-4.428611,"eighty":-1.976923,"marketCap":467647554},{"date":"2025-02-14","current":-9.436496,"twenty":-8.210314,"median":-4.428611,"eighty":-1.976923,"marketCap":466172326},{"date":"2025-02-21","current":-9.61567,"twenty":-8.252773,"median":-4.428611,"eighty":-1.976923,"marketCap":475023699},{"date":"2025-02-28","current":-8.133309,"twenty":-8.313066,"median":-4.428611,"eighty":-1.976923,"marketCap":458865000},{"date":"2025-03-07","current":-8.519356,"twenty":-8.326625,"median":-4.428094,"eighty":-1.976367,"marketCap":480645000},{"date":"2025-03-14","current":-8.137254,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":459087604},{"date":"2025-03-21","current":-8.207403,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":463045255},{"date":"2025-03-28","current":-8.16356,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":460571723},{"date":"2025-04-04","current":-7.690056,"twenty":-8.331904,"median":-4.428094,"eighty":-1.976367,"marketCap":433857574},{"date":"2025-04-11","current":-7.356849,"twenty":-8.331904,"median":-4.428611,"eighty":-1.976923,"marketCap":415058728},{"date":"2025-04-17","current":-7.536606,"twenty":-8.331904,"median":-4.428611,"eighty":-1.976923,"marketCap":425200210},{"date":"2025-04-25","current":-8.365238,"twenty":-8.335423,"median":-4.428094,"eighty":-1.976367,"marketCap":471949972},{"date":"2025-05-02","current":-9.208299,"twenty":-8.359977,"median":-4.428094,"eighty":-1.976367,"marketCap":519513839}],"updateTime":1746348604730}}}